Evidence map›Paper›PMID 28511703›Full record

ArticleBMC neurology2017

Mindfulness-based stress reduction for people with multiple sclerosis - a feasibility randomised controlled trial.

Robert Simpson, Frances S Mair, Stewart W Mercer

Registry-linked trialAbstract read
In one paragraph

Article in BMC neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02136485 (Mindfulness-based Stress Reduction in Multiple Sclerosis - a Randomised Controlled Trial), which is not on this map. Cited by 22 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02136485 nacompletednot on this map

Mindfulness-based Stress Reduction in Multiple Sclerosis - a Randomised Controlled Trial

TypeinterventionalSponsorNHS Greater Glasgow and ClydeRan2014 to 2016Enrolled50ConditionsMultiple SclerosisArmsMindfulness-based stress reduction (MBSR), waiting list control
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Cognitive impairment in multiple sclerosis: from phenomenology to neurobiological mechanisms.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The influence of trait mindfulness on depression in multiple sclerosis: potential implications for treatment.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020
    Article
  19. Behavioral Interventions in Multiple Sclerosis.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Robert SimpsonGeneral Practice and Primary Care, Institute of Health and Wellbeing, University of Glasgow, House 1, 1 Horselethill Road, Glasgow, Scotland, G12 9LX, UK. Robert.Simpson@glasgow.ac.uk.
Frances S MairGeneral Practice and Primary Care, Institute of Health and Wellbeing, University of Glasgow, House 1, 1 Horselethill Road, Glasgow, Scotland, G12 9LX, UK.
Stewart W MercerGeneral Practice and Primary Care, Institute of Health and Wellbeing, University of Glasgow, House 1, 1 Horselethill Road, Glasgow, Scotland, G12 9LX, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultiple sclerosis (MS) is a stressful condition. Mental health comorbidity is common. Stress can increase the risk of depression, reduce quality of life (QOL), and possibly exacerbate disease activity in MS. Mindfulness-Based Stress Reduction (MBSR) may help, but has been little studied in MS, particularly among more disabled individuals.

methodsThe objective of this study was to test the feasibility and likely effectiveness of a standard MBSR course for people with MS. Participant eligibility included: age > 18, any type of MS, an Expanded Disability Status Scale (EDSS) </= 7.0. Participants received either MBSR or wait-list control. Outcome measures were collected at baseline, post-intervention, and three-months later. Primary outcomes were perceived stress and QOL. Secondary outcomes were common MS symptoms, mindfulness, and self-compassion.

resultsFifty participants were recruited and randomised (25 per group). Trial retention and outcome measure completion rates were 90% at post-intervention, and 88% at 3 months. Sixty percent of participants completed the course. Immediately post-MBSR, perceived stress improved with a large effect size (ES 0.93; p < 0.01), compared to very small beneficial effects on QOL (ES 0.17; p = 0.48). Depression (ES 1.35; p < 0.05), positive affect (ES 0.87; p = 0.13), anxiety (ES 0.85; p = 0.05), and self-compassion (ES 0.80; p < 0.01) also improved with large effect sizes. At three-months post-MBSR (study endpoint) improvements in perceived stress were diminished to a small effect size (ES 0.26; p = 0.39), were negligible for QOL (ES 0.08; p = 0.71), but were large for mindfulness (ES 1.13; p < 0.001), positive affect (ES 0.90; p = 0.54), self-compassion (ES 0.83; p < 0.05), anxiety (ES 0.82; p = 0.15), and prospective memory (ES 0.81; p < 0.05).

conclusionsRecruitment, retention, and data collection demonstrate that a RCT of MBSR is feasible for people with MS. Trends towards improved outcomes suggest that a larger definitive RCT may be warranted. However, optimisation changes may be required to render more stable the beneficial treatment effects on stress and depression.

trial registrationClinicalTrials.gov Identifier NCT02136485 ; trial registered 1st May 2014.

Indexed as

MindfulnessAnxietyAnxiety DisordersDepressionHumansMental HealthMultiple SclerosisOutcome Assessment, Health CarePersons with DisabilitiesQuality of LifeResearch DesignStress, PsychologicalWaiting Lists

Identifiers

PMID28511703
PMCPMC5434553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.